2015 annual financial data

Theravance Biopharma, Inc. - Ordinary Shares 2015 Operating margin

Theravance Biopharma, Inc. - Ordinary Shares 2015 operating margin with verifie…

Direct answer

Operating margin was -431.8%.

Operating income was -181,899,000 USD and net income was -182,219,000 USD.
Operating cash flow was -168,857,000 USD.

Get free Theravance Biopharma, Inc. - Ordinary Shares email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
42,126,000 USD
Operating income
-181,899,000 USD
Net income
-182,219,000 USD
Operating cash flow
-168,857,000 USD